Abstract
The induction of a potent and long-lasting immunity is one of the most important elements to consider in developing an effective vaccine. DNA vaccines induce markedly stronger CD8+ cytotoxic T lymphocyte (CTL) activity than do traditional peptide vaccines through their particular mechanism of antigen presentation mediated by MHC class I molecules. Induction of CTL specific to pathogenic viruses is thought to provide a reliable means of protecting a host from infection and halting disease progression, as these cells can directly recognize and lyse infected cells. However, in most of the early studies showing induction of pathogen-specific CTL, antigen-encoding immunogenic DNA alone was used and DNA vectors encoding immunomodulating molecules were not considered. It now appears that various types of immunomodulatory molecules such as cytokines (IL-1 [1], IL-2 [2], IL-12 [3], IFN-γ [4], IL-7 [5–7], and GM-CSF [8,9]), chemokines (TCA-3 [10], RANTES [11], MIP-1 [11]), and costimulatory molecules (CD40L [12], B7-1 [13] and B7-2 [14]) could enhance or modify the specific immune responses elicited by DNA immunization (see Table 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nencioni, L., Villa, L., Tagliabue, A., Antoni, G., Presentini, R., Perin, F., et al. (1987) In vivo immunostimulating activity of the 163–171 peptide of human IL-1beta. J. Immunol. 139, 800–804.
Xim, K. Q., Hamajima, K., Saski, S., Honsho, A., Tsuji, T., Ishii, N., Cao, X.-R., Lu, Y., Fukushima, J., Kawamoto, S., and Okuda, K., (1998) Intranasal co-inoculation of IL-2 expression plasmid with AIDS DNA vaccine enhances all-mediated immunity against HIV-1. Immunology 94, 438–444.
Alfonso, L. C. C., Scharton, T. M., Viera, L. Q., Wysocka, M., Trinchieri, G., and Scott, P. (1994) The adjuvant effect of interleukin-12 in a vaccine against Leish-mania major. Science 263, 235–237.
Playfair, J. H., and De, S. J. (1987) Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice. Clin. Exp. Immunol. 67, 5–10.
Bui, T., Faltynek, C. R., and Ho, R. J. (1994) Biologic response of recombinant interleukin-7 on herpes simplex virus infection in guinea pigs. Vaccine 12, 646–652.
Bui, T., Faltynek, C., and Ho, R. J. (1994) Differential disposition of soluble a liposomes-formulated human recombinant interleukin-7: Effect on blood lymphocyte population in guinea pigs. Pharm. Res. 11, 633–641.
Bui, T., Dykers, T., Hu, S.-L., Faltynek, C. R., and J., H. R. (1994) Effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cell-mediated immune responses to a recombinant HIV-envelope protein. J. AIDS 7, 799–806.
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., et al. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539–3543.
Xiang, Z. Q., and Ertl, H. C. J. (1995) Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2, 129–135.
Laning, J., Kawasaki, H., Tanaka, E., Luo, Y., and Dorf, M. E. (1994) Inhibition of in vivo tumor growth by the beta chemokine, TCA3. J. Immunol. 153, 4625–4635.
Schrum, S., Probst, P., Fleischer, B., and Zipfer, P. F. (1996) Synthesis of the cc-chemokines Mip-1a, Mip-1b, and RANTES is associated with a type 1 immune response. J. Immunol. 157, 3598–3604.
Yang, Y., and Wilson, J. M. (1996) CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273, 1862–1864.
Freeman, G. J., Gray, G. S., Gimmi, C. D., Lombard, D. B., Zhou, L.-J., White, M., et al. (1991) Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174, 625–631.
Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Gribben, J. G., Ng, J. W., et al. (1993) Murine B7-2. An alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178, 2185–2192.
Tsuji, T., Hamajima, K., Fukushima, J., Xin, K.-Q., Ishii, N., Aoki, I., et al. (1997) Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J. Immunol. 158, 4008–4014.
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546–549.
Krieg, A. M. (1996) Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA. Trends Microbiol. 4, 73–77.
Iwasaki, A., Stiernholm, B. J. N., Chan, A. K., Bernstein, N. L., and Barber, B. H. (1997) Enhanced CTL responses mediated by plasmid DNA immunogens encoding co-stimulatory molecules and cytokines. J. Immunol. 158, 4591–4601.
Tsuji, T., Hamajima, K., Ishii, N., Aoki, I., Fukushima, J., Xin, K. Q., et al. (1997) Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen. Eur. J. Immunol. 27, 782–787.
Okuda, K., Bukawa, H., Hamajima, K., Kawamoto, S., Sekigawa, K., Yamada, Y., et al. (1995) Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV-1 env and rev gene products. AIDS Res. Hum. Retroviruses 11, 933–943.
Okada, E., Sasaki, S., Ishii, N., Aoki, I., Yasuda, T., Nishioka, K., et al. (1997) Intranasal immunization of a DNA vaccine with interleukin 12 and granulocyte-macrophage colony-stimulating factor (GM-CSF) expressing plasmids in liposomes induce strong mucosal and cell-mediated immune response against HIV-1 antigens. J. Immunol. 159, 3638–3647.
Kim, J. J., Ayyavoo, V., Bagarazzi, M. L., Chattergoon, M. A., Dang, K., Wang, B., et al. (1997) In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158, 816–826.
Nicola, N. A. (1989) Hemopoietic cell growth factors and their receptors. Annu. Rev. Biochem. 58, 45–77.
Reed, S. G., Pihl, D. L., Conlon, P. J., and Grabstein, K. H. (1989) IL-1 as adjuvant. Role of T cells in the augmentation of specific antibody production by recombinant human IL-1 alpha. J. Immunol. 142, 3129–3133.
Abraham, E., and Shah, S. (1992) Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response. J. Immunol. 149, 3719–3726.
Weinberg, A., and Merigan, T. C. (1988) Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines. J. Immunol. 140, 294–299.
Heath, A. W., and Playfair, J. H. L. (1993) Cytokines as immunological adjuvants. Vaccine 7, 427–434.
Dasis, M. L., Bernhard, H., Shiota, F. M., Hand, S. L., Gralow, J. R., Huseby, E. S., et al. (1996) Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccine. Blood 88, 202–210.
Tao, M. H., and Levy, R. (1993) Idiotype GM-CSF fusion protein as a vaccine for B cell lymphoma. Nature 362, 755–758.
Kim, J. J., Ayyavoo, V., Bagarazzi, M. L., Chattergoon, M. A., Dang, K., Wang, B., et al. (1997) Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J. Immunol. 158, 816–826.
Tsuji, T., Fukushima, J., Hamajima, K., Ishii, N., Aoki, I., Bukawa, H., Ishigatsubo, Y., Tani, K., Okubo, T., Dorf, M. E., and Okuda, K. (1997) HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine. Immunology 90, 1–6.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Okuda, K., Kawamoto, S., Fukushima, J. (2000). Cytokine and Costimulatory Factor-Encoding Plasmids as Adjuvants for DNA Vaccination. In: Lowrie, D.B., Whalen, R.G. (eds) DNA Vaccines. Methods in Molecular Medicine™, vol 29. Humana Press. https://doi.org/10.1385/1-59259-688-6:197
Download citation
DOI: https://doi.org/10.1385/1-59259-688-6:197
Publisher Name: Humana Press
Print ISBN: 978-0-89603-580-5
Online ISBN: 978-1-59259-688-1
eBook Packages: Springer Protocols